Research reference only. Not medical advice. Most compounds are not FDA-approved. These are research chemicals, not for human consumption. Consult a qualified clinician.Read methodology Terms update on 18 Dec 2026
← Back to Research Index
Compare Evaluate Matrix Half-Life
Dossier · № 54 of 110 Updated Nov 17, 2026

Selank

Tuftsin analog TP-7

RUSSIA-APPROVED + ANECDOTAL · TUFTSIN ANALOG PEPTIDE (ANXIOLYTIC/NOOTROPIC)

▓ 69 indexed citations across PubMed (66), EuropePMC (3).

Citation breakdown by evidence tier

← weaker evidence  ·  stronger evidence →

69 citations across 5 tiers

Tap any tier to jump to that section of the bibliography.

Background

Selank is a nootropic anxiolytic peptide based drug developed by the Institute of Molecular Genetics of the Russian Academy of Sciences. Selank is a heptapeptide with the sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro (TKPRPGP). It is a synthetic analogue of the human tuftsin.

→ Wikipedia

Mechanism of action

Modulates GABAergic, serotonergic, and enkephalin systems; immune modulation

Researched effects

Anxiolytic (GABA modulation); nootropic; stress reduction; immune modulation; no sedation

Live evidence

Live signals refreshed daily. Current as of November 19, 2026.

Dosing reported in literature

250 mcg intranasal daily (0.15% solution, anxiolytic starting dose, range up to 500 mcg/day per r/Peptides wiki)

→ Semenova TP/Inozemtseva LS Russian Selank anxiolytic trials; r/Peptides wiki dosing consensus

Known concerns

Rare hypersensitivity; nasal irritation

Top-ranked picks

10 pre-curated authoritative sources, ranked by journal tier and study weight.

  1. [Optimization of the treatment of anxiety disorders with selank].

    Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova · 2015 — RANDOMISED CONTROLLED TRIALS · AUTHORITY 73.5

  2. [Efficacy and possible mechanisms of action of a new peptide anxiolytic selank in the therapy of generalized anxiety disorders and neurasthenia].

    Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova · 2008 — RANDOMISED CONTROLLED TRIALS · AUTHORITY 72.8

  3. [A comparison of the anxiolytic effect and tolerability of selank and phenazepam in the treatment of anxiety disorders].

    Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova · 2014 — CLINICAL TRIALS · AUTHORITY 68.4

  4. Tuftsin - Properties and Analogs.

    Current medicinal chemistry · 2017 — REVIEWS · AUTHORITY 53.7

  5. [Comparison of anticoagulant effects of regulatory proline-containing oligopeptides. Specificity of glyprolines, semax, and selank and potential of their practical application].

    Izvestiia Akademii nauk. Seriia biologicheskaia · 2006 — REVIEWS · AUTHORITY 52.6

  6. Selank, a Peptide Analog of Tuftsin, Attenuates Aversive Signs of Morphine Withdrawal in Rats.

    Bulletin of experimental biology and medicine · 2022 — RESEARCH ARTICLES · AUTHORITY 34.2

  7. Development of Peptide Biopharmaceuticals in Russia.

    2022 — RESEARCH ARTICLES · AUTHORITY 34.2

  8. The Influence of Selank on the Level of Cytokines Under the Conditions of "Social" Stress.

    Current reviews in clinical and experimental pharmacology · 2021 — RESEARCH ARTICLES · AUTHORITY 34.1

  9. Sedative-Hypnotic Agents That Impact Gamma-Aminobutyric Acid Receptors: Focus on Flunitrazepam, Gamma-Hydroxybutyric Acid, Phenibut, and Selank.

    Journal of clinical pharmacology · 2021 — RESEARCH ARTICLES · AUTHORITY 34.1

  10. Functional Connectomic Approach to Studying Selank and Semax Effects.

    Doklady biological sciences : proceedings of the Academy of Sciences of the USSR, Biological sciences sections · 2020 — RESEARCH ARTICLES · AUTHORITY 34.0

Full citation library

Year distribution

Randomised Controlled Trials

2
  1. 1.

    Medvedev VE, Tereshchenko ON, Kost NV, Ter-Israelyan AY, et al. · Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova · 2015 · PMID 26356395

    To compare the efficacy and tolerability of monotherapy with phenazepam to complex treatment with the peptide preparation selank and phenazepam in patients with anxiety disorders. Authors explored the anxiolytic effect and tolerability of monotherapy with phenazepam (30 patients) and complex treatment with selank and phenazepam (40 patients) in anxiety-phobic, hypochondriac and somatoform disorders (ICD-10 items F40.2-9, F41.1-9, F45.0-2). Therapeutic effect was assessed clinically and with HDRS…

  2. 2.

    Zozulia AA, Neznamov GG, Siuniakov TS, Kost NV, et al. · Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova · 2008 · PMID 18454096

    Sixty-two patients with generalized anxiety disorder (GAD) and neurasthenia were studied. The effect of selank (30 patients) was compared to that of medazepam (32 patients). Patient's state was assessed with psychometric scales (Hamilton, Zung, CGI). Enkephalin activity in the blood serum was measured as well. The anxiolytic effects of both drugs were similar but selank had also antiasthenic and psychostimulant effects. The clinical-biological study revealed that patients with GAD and neurasthen…

Clinical Trials

1
  1. 3.

    Medvedev VE, Tereshchenko ON, Israelian AIu, Chobanu IK, et al. · Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova · 2014 · PMID 25176261

    Objective. To study the efficacy and tolerability of the new anxyolytic peptide selank in comparison with phenazepam. Material and methods. A comparative study of the anxiolytic effect and tolerability of selank and phenazepam was carried out in 60 patients with phobic-anxiety- and somatoform disorders (F40.2-9, F41.1-9, F45.0-1 by ICD-10) were examined. Results Pronounced anxiolytic and mild nootropic effects of selank were demonstrated. The anxiolytic effect lasted for a week after last receiv…

Reviews

2
  1. 4.

    Siebert A, Gensicka-Kowalewska M, Cholewinski G, Dzierzbicka K · Current medicinal chemistry · 2017 · PMID 28745220

    Immunomodulation is one of the significant therapeutic strategies. It includes both stimulation and suppression of the immune system by a variety of substances called immunomodulators, designed to regulate the immune response of the organism against infections of varying etiology. An example of such a substance is tuftsin (TKPA) 3 (Fig. (1)). In this paper were included tuftsin derivatives, which were described over the years, their together with biological activity and clinical potential. We re…

  2. 5.

    Liapina LA, Pastorova VE, Obergan TIu, Samonina GE, et al. · Izvestiia Akademii nauk. Seriia biologicheskaia · 2006 · PMID 16634437

    Experimental and theoretical demonstration of different effect of certain regulatory peptides (RPs) on blood coagulation is available. The problem of the role of RPs in hemostatic processes becomes particularly significant since, first, the peptides are widespread in nature both in animal and plant tissues, second, there is a relationship between the peptide structure and function and, third, both natural and synthetic peptides are used in practical medicine to correct functions of some factors…

Research Articles

63
  1. 6.

    Fomenko EV, Bobyntsev II, Ivanov AV, Belykh AE, et al. · Bulletin of experimental biology and medicine · 2019 · PMID 31243679

    We studied the effects of Selank on morphological parameters of the liver in Wistar male rats subjected to chronic foot-shock stress. Selank was injected intraperitoneally in doses of 100, 300 and 1000 μg/kg 15 min before each stress session. Morphological and morphometrical analysis showed that chronic foot-shock stress induced hydropic degeneration of hepatocytes, an increase of the nucleus/cytoplasm ratio due to an increase in the area of nuclei and reduction of the cytoplasm area, the appear…

  2. 7.

    Konstantinopolsky MA, Chernyakova IV, Kolik LG · Bulletin of experimental biology and medicine · 2022 · PMID 36322304

    Activity of a peptide tuftsin analogue Selank was studied in outbred rats using the naloxone-precipitated morphine withdrawal model. Single intraperitoneal injection of Selank in an anxiolytic dose of 0.3 mg/kg reduced the total index of morphine withdrawal syndrome by 39.6%, significantly (р<0.0001) attenuated convulsive reactions, ptosis, and posture disorders, and 9-fold increased the tactile sensitivity threshold in morphine-dependent rats in comparison with the group of active control; at t…

  3. 8.

    Kolomin T, Morozova M, Volkova A, Shadrina M, et al. · Molecular immunology · 2014 · PMID 24291245

    Previous studies have shown that synthetic tuftsin analogue Selank and its fragments cause a number of alterations in the expression of certain genes involved in inflammation in mouse spleen. In this work we studied the effect of Selank and its short fragment Gly-Pro on the temporary dynamics of C3, Casp1, Il2rg, and Xcr1 genes expression in mouse spleen after single intraperitoneal injection (100 μg/kg) of peptides using real-time PCR method. We found a significant 3-fold decrease in the C3 mRN…

  4. 9.

    Filatova E, Kasian A, Kolomin T, Rybalkina E, et al. · Frontiers in pharmacology · 2017 · PMID 28293190

    Clinical studies have shown that Selank had an anxiolytic effect comparable to that of classical benzodiazepine drugs, which can enhance the inhibitory effect of GABA by allosteric modulation of GABA

  5. 10.

    Volkova A, Shadrina M, Kolomin T, Andreeva L, et al. · Frontiers in pharmacology · 2016 · PMID 26924987

    Clinical studies have shown the similarity of the spectrum of physiological effects of Selank and classical benzodiazepines, such as diazepam and phenazepam. These data suggest that there is a similar basis of their mechanism of action. To test this hypothesis we studied the effect of Selank and GABA on the expression of genes involved in neurotransmission. We analyzed the expression of 84 genes involved in neurotransmission (e.g., major subunit of the GABA receptor, transporters, ion channels,…

  6. 11.

    Panikratova YR, Lebedeva IS, Sokolov OY, Rumshiskaya AD, et al. · Doklady biological sciences : proceedings of the Academy of Sciences of the USSR, Biological sciences sections · 2020 · PMID 32342318

    The present study was aimed at the assessment of effects of anxiolytic Selank and nootropic Semax on the whole-brain resting-state functional connectivity (FC) of each of the predefined regions of interest (ROIs) in 52 healthy participants. The ROIs included amygdala (one of the key regions for the regulation of anxiety) and dorsolateral prefrontal cortex (DLPFC; the key region for executive functions, including working memory) in the right and left hemisphere. Resting-state fMRI was carried out…

  7. 12.

    Vyunova TV, Andreeva L, Shevchenko K, Myasoedov N · Protein and peptide letters · 2018 · PMID 30255741

    Anxiety and mood disorders are the most abundant mental health problems worldwide. The commonly used in clinical practice anxiolytics are focused on pharmacological modulation of brain GABA receptor system activity. As a rule, their use presents a wide spectrum of clinical issues such as dependence, memory impairment and etc. There is an increasing appreciation of the role of neuropeptides and bioactive lipids in the pathophysiology of mood and anxiety disorders as "mild" agents. Heptapeptide Se…

  8. 13.

    Kasian A, Kolomin T, Andreeva L, Bondarenko E, et al. · Behavioural neurology · 2017 · PMID 28280289

    It was shown that the anxiolytic effect of Selank is comparable to that of classical benzodiazepine drugs and that the basis of their mechanism of action may be similar. These data suggest that the presence of Selank may change the action of classical benzodiazepine drugs. To test this hypothesis, we evaluated the anxiolytic activity of Selank and diazepam in rats both under conditions of unpredictable chronic mild stress and in its absence, after the individual and combined administration of th…

  9. 14.

    Leonidovna YA, Aleksandrovna SM, Aleksandrovna TA, Aleksandrovna BO, et al. · Current reviews in clinical and experimental pharmacology · 2021 · PMID 32621722

    It was previously thought that inflammation and an immune response were the only factors capable of causing IL-1β, IL-6 and other cytokine`s production. In recent years data have appeared that stressful effects can also occupy an important place, enhancing production of IL- 1β, IL-6 and other cytokines; the result will be a change in the functional activity of a particular cell element, for example immunocompetent cells with subsequent development of inflammation, or a change in the functional a…

  10. 15.

    Kolomin T, Shadrina M, Andreeva L, Slominsky P, et al. · Regulatory peptides · 2011 · PMID 21609736

    Previous studies have shown that synthetic tuftsin analogue Selank causes a transcriptomic response in the rat hippocampus and in spleen cells and may participate in the regulation of inflammatory processes in the body. In this work we studied the effect of Selank and two of its fragments on the expression of genes involved in processes of inflammation. We analyzed the expression of 84 genes involved in processes of inflammation (e.g., chemokines, cytokines, and its receptors) in mouse spleen 6…

  11. 16.

    Kolik LG, Nadorova AV, Antipova TA, Kruglov SV, et al. · Bulletin of experimental biology and medicine · 2019 · PMID 31625062

    The effects of a peptide anxiolytic Selank synthesized on the basis of the endogenous peptide tuftsin on memory impairment and content of brain-derived neurotrophic factor (BDNF) in brain structures were analyzed in outbred rats receiving 10% ethanol as the only source of fluid for 30 weeks. In the object recognition test, Selank (0.3 mg/kg a day, 7 days, intraperitoneally) produced a cognitive-stimulating effect in 9 months rats not exposed to ethanol (p<0.05) and prevented the formation of eth…

  12. 17.

    Kozlovskii II, Danchev ND · Neuroscience and behavioral physiology · 2003 · PMID 14552529

    The actions of the synthetic heptapeptide preparation Selank on learning and memory processes in rats with initially low levels of learning ability were compared with those in normal rats, using a method based on acquisition of a conditioned active avoidance reflex, with repeated administration of peptide 15 min before the start of training sessions for four days. The effects of Selank (300 microg/kg) were compared with the effects of the nootrope piracetam (400 mg/kg). These experiments showed…

  13. 18.

    Povarov IS, Kondratenko RV, Derevyagin VI, Myasoedov NF, et al. · Bulletin of experimental biology and medicine · 2017 · PMID 28361410

    Application of anxiolytic drug Selank to hippocampal slices increased the amplitude and discharge rate of spontaneous inhibitory postsynaptic currents in rat hippocampal pyramidal CA1 neurons. In some neurons, Selank-induced up-regulation of spontaneous inhibitory postsynaptic currents was preceded by a transient decrease in this activity. In the examined concentration range (1-8 μM), Selank demonstrated no significant dose-dependence.

  14. 19.

    Mukhina AY, Medvedeva OA, Svishcheva MV, Shevchenko AV, et al. · Bulletin of experimental biology and medicine · 2019 · PMID 31236882

    We studied the effects of Selank on intestinal microbiota in Wistar male rats subjected to chronic restraint stress. Selank was injected intraperitoneally in doses of 80, 250 and 750 μg/kg 15 min before stress exposure. Chronic restraint stress led to a decrease in the content of obligate microflora, while the content of opportunistic microorganisms increased. Selank restored intestinal microbiota presumably via central (neurotropic) and peripheral (immunotropic) mechanisms.

  15. 20.

    Sarkisova KIu, Kozlovskiĭ II, Kozlovskaia MM · Zhurnal vysshei nervnoi deiatelnosti imeni I P Pavlova · 2008 · PMID 18661785

    A synthetic derivative of the endogenous peptide tuftsin heptapeptide selank (Thr-Lys-Pro-Arg-Pro-Gly-Pro) possesses an anxiolytic and psychostimulant effect, and represents a working element of a new peptide drug having completed the third phase of the clinical testing as a selective anxiolytic. The neurobiochemical spectrum of selank action combines mechanisms which are characteristics of antidepressants and psychostimulants: activation of the brain monoaminergic systems, dopamine synthesis an…

  16. 21.

    Semenova TP, Kozlovskiĭ II, Zakharova NM, Kozlovskaia MM · Eksperimental'naia i klinicheskaia farmakologiia · 2010 · PMID 20919548

    The effect of selank (Thr-Lys-Pro-Arg-Pro-Gly-Pro), which is a synthetic derivative of the endogenous tetrapeptide tuftsin (stable with respect to tissue peptidases), on the learning and memory processes and metabolism of serotonin (5-HT) have been experimentally studied on Wistar rats. The animals were trained with food reward in 30 trials per day. Selank (300 microg/kg) or saline were injected after the 10th trial. Elaboration of conditioned reflex with food reward was continued 30 min later.…

  17. 22.

    Mukhina AY, Mishina ES, Bobyntsev II, Medvedeva OA, et al. · Bulletin of experimental biology and medicine · 2020 · PMID 32651826

    We studied the effects of Selank on the condition of the colon wall in Wistar male rats subjected to restraint stress. Selank was injected intraperitoneally in doses of 80, 250, and 750 μg/kg 15 min before stress exposure. In rats subjected to stress, signs of atrophy, inflammatory reaction, and changes in the number and functional activity of mast cells were observed against the background of increased corticosterone level. Selank administration led to a decrease in corticosterone levels, reduc…

  18. 23.

    Semenova TP, Kozlovskaya MM, Zuikov AV, Kozlovskii II, et al. · Bulletin of experimental biology and medicine · 2005 · PMID 16848230

    We studied the seasonal effects of peptide preparation Selank on orientation and exploratory activity in 36 arctic ground squirrels Citellus undulatus in the open-field and hole-board tests. Selank most significantly increased behavioral activity of hibernating animals in the spring and fall. The test peptide had no effect on locomotor activity of animals. The selective stimulatory effect of Selank on exploratory behavior of hibernating animals was season-dependent. The maximum effect was observ…

  19. 24.

    Vasil'eva EV, Kondrakhin EA, Salimov RM, Kovalev GI · Eksperimental'naia i klinicheskaia farmakologiia · 2016 · PMID 29787664

    Pharmacological effects of intraperitoneal (i.p.) and intranasal (i.n.) administration of heptapeptide selank (300 μg/kg/day for 5 days), known to possess anxiolytic and nootropic properties, were compared by studying the elevated-plus-maze behavior of inbred BALB/c and C57BL/6 mice and measuring the binding of markers to NMDA and GABA receptors of brain. The anxiolytic and nootropic efficiency of selank administered via both routes was observed only in BALB/c mice, which were characterized by i…

  20. 25.

    Pavlov TS, Sanzhieva LTs, Samonina GE, Sergeev VI, et al. · Rossiiskii fiziologicheskii zhurnal imeni I.M. Sechenova · 2005 · PMID 15835541

    The influence of a new heptapeptide Selank on microcirculation in anesthetized white rats was investigated. Selank (Thr-Lys-Pro-Arg-Pro-Gly-Pro) is a new synthetic anxiolytic which exerts obvious antiulcerogenic action and promotes healing of experimental ulcers. Action of the peptide on gastric blood flow in the stomach by using the method ofhydrogenic clearance and Selank action on mesenteric lymphatic contractility by microscopical observation in situ, were studied. Selank fail to influence b…

  21. 26.

    Zozulya AA, Kost NV, Yu Sokolov O, Gabaeva MV, et al. · Bulletin of experimental biology and medicine · 2001 · PMID 11550013

    Examination of patients with various forms of anxiety and phobic disorders (according to DSM-4 criteria) demonstrated a considerable shortening of enkephalin half-life and reduced total enkephalinase activity in the blood during generalized anxiety, but not during panic disorders and agoraphobia. This was probably related to low blood concentration of endogenous inhibitors of enkephalin-degrading enzymes in patients with generalized anxiety disorders. Heptapeptide Selank (Thr-Lys-Pro-Arg-Pro-Gly…

  22. 27.

    Uchakina ON, Uchakin PN, Miasoedov NF, Andreeva LA, et al. · Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova · 2008 · PMID 18577961

    The purpose of this article was to study the immunotropic effects of the new neurotrophic heptapeptide selank. The experiments in vitro revealed that the drug in concentration 10-7 M completely suppressed gene expression by peripheral blood IL-6 of patients with depression but not of the healthy controls. At the same time, the significant increase (p<0,05) of IL-6 concentration was observed in the cell culture of peripheral blood of patients in the presence of selank. The changes of the Th1/Th2…

  23. 28.

    Fomenko EV, Bobyntsev II, Kryukov AA, Ivanov AV, et al. · Bulletin of experimental biology and medicine · 2017 · PMID 28853100

    We studied the effect of Selank administered intraperitoneally in doses of 100, 300, and 1000 μg/kg to male Wistar rats 15 min prior to restraint stress on the content of aminotransferases and total protein concentration in blood serum and intensity of free radical oxidation in the liver. Under conditions of acute restraint stress, Selank in doses of 100 and 300 μg/kg decreased catalase and superoxide dismutase activities and malondialdehyde concentration and increased total antioxidant activity…

  24. 29.

    Kolomin TA, Agapova TIu, Agniullin IaV, Shram SI, et al. · Zhurnal vysshei nervnoi deiatelnosti imeni I P Pavlova · 2013 · PMID 24450168

    The effect of single and course administration of Selank (Thr-Lys-Pro-Arg-Pro-Gly-Pro) in the dose 200 microg/kg on the rat hippocampus transcriptional profile were studied using cDNA microarray technology. It was shown that mRNA levels of 36 genes changed more than 2-fold after a single intranasal Selank administration, and 20 genes--after course administration. It should be noted that most of them encode proteins associated with the plasma membrane (including transmembrane proteins). This sugg…

  25. 30.

    Kolik LG, Nadorova AV, Seredenin SB · Bulletin of experimental biology and medicine · 2016 · PMID 27878720

    The effect of non-benzodiazepine anxiolytics on the ethanol-induced hyperlocomotion and behavioral sensitization was assessed in male DBA/2 mice. Selank that enhances activity of the endogenous opioid system (0.3 mg/kg, intraperitoneally), similar to the nonselective opiate receptor blocker naloxone (1.0 mg/kg, intraperitoneally), prevented the development of ethanol-induced (2.0 g/kg intraperitoneally) hyperlocomotion, in contrast to σ1-receptors agonist Afobazole (1.0 mg/kg, intraperitoneally)…

  26. 31.

    Meshavkin VK, Kost NV, Sokolov OY, Zolotarev YA, et al. · Bulletin of experimental biology and medicine · 2006 · PMID 17415472

    Peptide anxiolytic selank (Thr-Lys-Pro-Arg-Pro-Gly-Pro) applied intraperitoneally in doses of 0.01, 0.1, 1.0, and 10.0 mg/kg to mice reduces behavioral manifestations of dopaminergic system induced by apomorphine in the verticalization test. This effect was comparable to that of atypical antipsychotic olanzapine in near-therapeutic doses (0.1 and 1.0 mg/kg, intraperitoneally) and was blocked with nonselective opioid receptor antagonist naloxone (10 mg/kg, intraperitoneally). Radioreceptor assay…

  27. 32.

    Semenova TP, kozlovskiĭ II, Zakharova NM, Kozlovskaia MM · Eksperimental'naia i klinicheskaia farmakologiia · 2009 · PMID 19803361

    Effects of the peptide drugs selank (Thr-Lys-Pro-Arg-Pro-Gly-Pro) and tuftsin (Thr-Lys-Pro-Arg) on the metabolism of serotonin (5-hydroxytryptamine, 5-HT) in the brain of Wistar rats preliminarily treated with the 5-HT-synthesis inhibitor p-chlorophenylalanine (PCPA, 320 mg/kg, i.p., 4 days before experiment) have been studied on a group of 87 matured rats. It is established that selank enhances the 5-HT metabolism in the brain stem 30 min after injection to animals pretreated with PCPA. In cont…

  28. 33.

    Kozlovskiĭ II, Danchev ND · Zhurnal vysshei nervnoi deiatelnosti imeni I P Pavlova · 2002 · PMID 12449836

    The action of a synthetic peptide Selank on learning and memory in active avoidance conditioning test was studied in rats with initially low learning ability and normal animals. The peptide was administered repeatedly 15 min prior the training session (4 days). The effect of Selank (300 micrograms/kg) was compared to that of Pyracetam (400 mg/kg). Selank was found to significantly improve learning in rats with low level ability even after a single administration on the first day of training sess…

  29. 34.

    Andreeva LA, Nagaev IY, Mezentseva MV, Shapoval IM, et al. · Doklady biological sciences : proceedings of the Academy of Sciences of the USSR, Biological sciences sections · 2010 · PMID 20506839

  30. 35.

    Pavlov TS, Samonina GE, Andreeva LA, Myasoedov NF, et al. · Doklady biological sciences : proceedings of the Academy of Sciences of the USSR, Biological sciences sections · 2004 · PMID 15508574

  31. 36.

    Slominsky PA, Shadrina MI, Kolomin TA, Stavrovskaya AV, et al. · Doklady biological sciences : proceedings of the Academy of Sciences of the USSR, Biological sciences sections · 2017 · PMID 28702721

    Parkinson's disease (PD) is the second most common severe neurodegenerative disorder that is characterized by progressive degeneration of dopaminergic neurons (DA neurons) in the substantia nigra pars compacta (SNpc) region of the brain. In the present study, we investigated the effects of the synthetic regulatory peptides Semax (analog of an ACTH 4-10 fragment (ACTH4-10)) and Selank (analog of immunomodulatory taftsin) on behavior of rats with 6-hydroxidopamine (6-OHDA) induced PD-like parkinso…

  32. 37.

    Kost NV, Sokolov OIu, Gabaeva MV, Grivennikov IA, et al. · Bioorganicheskaia khimiia · 2001 · PMID 11443939

    A dose-dependent effect of synthetic heptapeptides Semax (Met-Glu-His-Phe-Pro-Gly-Pro) and Selank (Thr-Lys-Pro-Arg-Pro-Gly-Pro) on the enkephalin-degrading enzymes of human serum was demonstrated. The inhibitory effects of Semax (IC50 10 microM) and Selank (IC50 20 microM) are more pronounced than those of puromycin (IC50 10 mM), bacitracin, and some other inhibitors of peptidases. Beside the heptapeptides, their pentapeptide fragments also possessed an inhibitory effect; tri-, tetra-, and hexap…

  33. 38.

    Semenova TP, Kozlovskaya MM, Zakharova NM, Kozlovskii II, et al. · Bulletin of experimental biology and medicine · 2007 · PMID 18683497

    Effects of selank on learning, memory, and attention to sensory stimuli of different modality were studied in adult Wistar rats treated with 6-hydroxydopamine (neurotoxin selectively damaging catecholaminergic neurons and their terminals) during the first 3 days of life. Selank (300 microg/kg) restored cognitive processes disordered by chronic artificial inhibition of the cerebral catecholaminergic system.

  34. 39.

    Ashmarin IP, Samonina GE, Lyapina LA, Kamenskii AA, et al. · Pathophysiology : the official journal of the International Society for Pathophysiology · 2005 · PMID 15837162

    The present concept of relative instability of regulatory peptides (RPs) in organisms must be amended. The recently characterized family of glyprolines and some other prolyl-glycyl-proline (PGP)-containing oligopeptides show the stability quite comparable with those of major pharmacological preparations. The ability of glyprolines to pass gastro-enteric tract barriers opens ways to per-oral administration of this new group of drugs such as semax, selank and their fragments. The most interesting…

  35. 40.

    Gan'shina TS, Kozlovskiĭ II · Eksperimental'naia i klinicheskaia farmakologiia · 2005 · PMID 16193654

    The effects of the new heptapeptide anxiolytic drug selank (300 mg/kg, i.v.) on the arterial pressure (AP), cerebral blood flow, heart rhythm, respiration, and the AP depression induced by acetylcholine injections was recorded in narcotized male cats. Selank produced a 32 +/- 4.3% decrease in the AP for the first 1-3 min after injection. The drug also induced a 24 +/- 2.8% increase in the cerebral blood flow for the first 5 - 10 min upon injection and then the blood flow was gradually restored o…

  36. 41.

    Rogozinskaya EY, Lyapina MG · Bulletin of experimental biology and medicine · 2017 · PMID 29181670

    Thromboelastography revealed anticoagulant effects of 3 glyproline oligopeptides (in various concentrations): His-Phe-Arg-Trp-Pro-Gly-Pro, Thr-Lys-Pro-Arg-Pro-Gly-Pro (Selank), and Pro-Gly-Pro. The parameters R, K, MA, S, TMA, and J changed to hypocoagulation direction in comparison to the control. At this, Selank demonstrated the maximal anticoagulation potency.

  37. 42.

    Zhurnal evoliutsionnoi biokhimii i fiziologii · 2008 · PMID 18727417

    The work presents results of study of role of heptapeptide Selank--an anxiolytic from group of biologically active peptides--in compensation of disturbed psychic and homeostatic functions in monkeys. New data have been obtained which indicate that an intranasal administration of Selank produces long-term changes of the monkeys' behavior disturbed during neurosis: elimination of fear and aggression and an increase of orientational-explorative activity as well as facilitation of handling reactions…

  38. 43.

    Semenova TP, Kozlovskaya MM, Zuikov AV, Kozlovskii II, et al. · Neuroscience and behavioral physiology · 2008 · PMID 18197389

    The effects of Selank, the active component of which is the heptapeptide Thr-Lys-Pro-Arg-Pro-Gly-Pro, which includes the tetrapeptide tuftsin and three natural levorotatory amino acids, on behavior and brain serotonin and noradrenaline levels were studied in adult rats subjected to antenatal hypoxia on days 14-16 of gestation. Administration of Selank (300 microg/kg, i.p.) improved sensory attention levels by factors of 2-3 (p < 0.01), facilitated the learning process by a factor of 1.5 (p < 0.0…

  39. 44.

    Kolik LG, Nadorova AV, Kozlovskaya MM · Bulletin of experimental biology and medicine · 2014 · PMID 24913576

    We studied the effects of selank on the development of symptoms of acute 48-h alcohol withdrawal in outbred rats drinking 10 % ethanol as the only source of fluid for 24 weeks. In alcohol-preferring animals (mean daily ethanol intake >5.0 g/kg) allowed free choice between 10 % ethanol and water, single intraperitoneal injection of selank in a dose of 0.3 mg/kg eliminated anxiety induced by ethanol withdrawal in tests elevated plus maze and social interaction tests and prevented the formation of…

  40. 45.

    Zolotarev IuA, Dadaian AK, Dolotov OV, Kozik VS, et al. · Bioorganicheskaia khimiia · 2006 · PMID 16637290

    Biologically active peptides evenly labeled with tritium were used for studying the in vitro and in vivo biodegradation of the peptides. Tritium-labeled peptides with a specific radioactivity of 50-150 Ci/mmol were obtained by high temperature solid phase catalytic isotope exchange (HSCIE) with spillover tritium. The distribution of the isotope label among all amino acid residues of these peptides allows the simultaneous determination of practically all possible products of their enzymatic hydro…

  41. 46.

    Narkevich VB, Kudrin VS, Klodt PM, Pokrovskiĭ AA, et al. · Eksperimental'naia i klinicheskaia farmakologiia · 2008 · PMID 19093364

    The effect of heptapeptide selank on the content of neurotransmitter monoamines and its metabolites in the brain structures of BALB/C and C57Bl/6 line mice under conditions of the open-field test were studied. Significant interstrain differences in the content of norepinephrine (NE), dopamine (DA), serotonin (5-HT) as well as in the levels of their metabolites in hippocampus, hypothalamus, striatum and frontal cortex of C57Bl/6 and BALB/C mice were demonstrated. In particular, the content of 5-H…

  42. 47.

    Pavlov TS, Samonina GE, Bakaeva ZV, Zolotarev YA, et al. · Bulletin of experimental biology and medicine · 2007 · PMID 18019011

    Antiulcer properties of a synthetic anxiolytic Selank and in vivo formed metabolites of this compound were studied on 3 experimental models of ulceration. The test peptides decreased the area of experimental gastric ulcers.

  43. 48.

    Kobylyanskii AG, Zolotarev YA, Andreeva LA, Grivennikov IA, et al. · Bulletin of experimental biology and medicine · 2017 · PMID 29063333

    We studied the effects of peptide drugs (HLDF-6, PGP, RPGP, and PGLP) and peptide pharmaceutical products (Semax, Selank, and thyroliberin) on proliferation and survival of mouse embryonic stem cells and their derivatives. Differentiation of mouse embryonic stem cells into neuronal precursors was evaluated. PGP and PGLP in concentrations of 10 and 0.1 μM, respectively, had little, but significant inhibitory effect on proliferative activity of cells. These peptides in concentrations of 10 and 0.1…

  44. 49.

    Kolomin TA, Shadrina MI, Slominskiĭ PA, Limborskaia S, et al. · Genetika · 2011 · PMID 21786679

    A study of the immunomodulating effect of selank showed that the total peptide and its fragment significantly change the expression of the genes for chemokines, cytokines, and their receptors in mouse spleen 6 and 24 h after administration of a single dose. Changes in the mRNA level of the majority of the genes under study were similarly observed after the administration of Gly-Pro, which was earlier identified as a selank pharmacophor, a minimum fragment with anitiviral activity. Pharmacologica…

  45. 50.

    Kozlovskiĭ II, Andreeva LA, Kozlovskaia MM, Nadorova AV, et al. · Eksperimental'naia i klinicheskaia farmakologiia · 2012 · PMID 22550852

    Peculiarities of the anxiolytic effects of selank (heptapeptide analog of taftsin) under reduced activity of opioid system upon acute administration of naloxone have been studied in BALB/C and C57BL/6 inbred mice with high and low levels of anxiety, with passive and active emotional stress reaction phenotypes in the open field (OF) test. Selank (0.25 mg/kg, i.p.) per se exhibited anxiolytic effect in BALB/C mice by increasing the general locomotor activity, with no effects on the behavior of C57…

  46. 51.

    Kolomin TA, Shadrina MI, Agniullin YV, Shram SI, et al. · Doklady. Biochemistry and biophysics · 2010 · PMID 20380151

  47. 52.

    Ershov FI, Uchakin PN, Uchakina ON, Mezentseva MV, et al. · Voprosy virusologii · 2009 · PMID 19882898

    The main objective of this study was to evaluate the antiviral properties of the glyproline Selank in both in vitro and in vivo against the influenza virus strain A/Aichi 2/68 (H3N2). The pronounced antiviral effect of the agent was detected in both systems. Selank added to the cell culture 24 hours before inoculation (a preventive use scheme) showed the highest efficiency, by completely suppressing viral reproduction. The in vivo studies also demonstrated that the highest survival of laboratory…

  48. 53.

    Semenova TP, Kozlovskaia MM, Zuĭkov AV, Kozlovskiĭ II, et al. · Rossiiskii fiziologicheskii zhurnal imeni I.M. Sechenova · 2006 · PMID 17385425

    The effects of Selank synthetic analog of Tuftsin, representing the heptapeptide forming Thr-Lys-Pro-Arg-Pro-Gly-Pro, on behavior and serotonin/noradrenalin concentrations in brain were investigated in adult rats exposed to hypoxia during 14-16 days of gestation. It was revealed that injection of Selank (300 mkg/kg, i/p) increased 2--3-fold (p < 0.01) the sensory attention, facilitated 1.5-fold the learning capacity (p < 0.01), normalized exploratory activity in the open field and hole board, an…

  49. 54.

    Mjasoedov NF, Andreeva LA, Grigorjeva ME, Obergan TY, et al. · Doklady biological sciences : proceedings of the Academy of Sciences of the USSR, Biological sciences sections · 2014 · PMID 25371249

  50. 55.

    Doyno CR, White CM · Journal of clinical pharmacology · 2021 · PMID 34396551

    There are many nonopioid central nervous system depressant substances that share a gamma-aminobutyric acid (GABA) receptor-related mechanism of action. These sedatives-hypnotics can be indicated to treat anxiety, seizures, depression, and insomnia but are also used as substances of abuse and used to facilitate sexual assault. Barbiturates, methaqualone, and glutethimide were among the first type A GABA receptor-mediated sedative-hypnotics. Their clinical use was limited for most indications by s…

  51. 56.

    Kozlovskiĭ II, Belozertsev IuF, Semenova TP, Zuĭkov AV, et al. · Eksperimental'naia i klinicheskaia farmakologiia · 2008 · PMID 18488898

    It has been shown that the peptide anxiolytic drug Selank recovers learning and memory impaired by damage of the noradrenergic (NA) brain system in Wistar rats after injection of the NA-synthesis inhibitor disulfiram, administration of neurotoxic compound 6-OHDA, or a combined induction of hypoxic hypoxia and hypercapnia. The main component of the Selank action is the stimulation of the search reflex aimed to distinguish an adequate adaptive response in the first trials of the learning session.…

  52. 57.

    Kozlovskiĭ II, Belozertsev FIu, Andreeva LA, Kozlovskaia MM · Eksperimental'naia i klinicheskaia farmakologiia · 2013 · PMID 24605419

    We have studied the ability of peptide anxiolytic selank (Thr-Lyz-Pro-Arg-Pro-Gly-Pro) to compensate for mnestic dysfunction caused by the administration of actinomycin D, which inhibits protein synthesis by blocking DNA-dependent RNA polymerase. The experiments were performed on white rats with acquired adaptive ability of spatial visual orientation in a 16-door labyrinth. The learning was based on the avoidance of electric skin irritation at alternating sites of escape reaction (site reflex).…

  53. 58.

    Inozemtseva LS, Karpenko EA, Dolotov OV, Levitskaya NG, et al. · Doklady biological sciences : proceedings of the Academy of Sciences of the USSR, Biological sciences sections · 2008 · PMID 18841804

  54. 59.

    Solov'ev VB, Gengin MT, Sollertinskaia TN, Latynova IV, et al. · Zhurnal evoliutsionnoi biokhimii i fiziologii · 2012 · PMID 22827026

    Effect of single selank administration on activity of carboxypeptidase H and of phenylmethylsulfonylfluoride-inhibited carboxypeptidase - enzymes detaching arginine and lysine from C-terminus of molecules-precursors of biologically active peptides was studied. The preparation has been shown to cause long, preserved for 24 h changes of activities of these carboxypeptidases. It is suggested that the change in activity of the studied enzymes can be one of mechanisms of regulation of level of neurop…

  55. 60.

    Sokolov OY, Meshavkin VK, Kost NV, Zozulya AA · Bulletin of experimental biology and medicine · 2002 · PMID 12432865

    Comparative study of plasma activities of enkephalin-degrading enzymes in mice with different phenotypes of emotional and stress reactions revealed significant differences between intact BALB/c and C57Bl/6 mice by the half-life of plasma leu-enkephalin. Selank in a dose of 100 micrograms/kg produced an anxiolytic effect in the open-field test and increased the half-life of plasma leu-enkephalin in BALB/c mice, but had no effect on behavioral reactions and enkephalinase activities in C57Bl/6 mice…

  56. 61.

    Kozlovskaya MM, Kozlovskii II, Val'dman EA, Seredenin SB · Neuroscience and behavioral physiology · 2003 · PMID 14969422

    White laboratory male rats, inbred male C57BL/6 and Balb/c mice, and male Wistar rats, all previously divided on the basis of the type of emotional reactivity, were used to compare the effects of ten peptide compounds of the tuftsin family and Selank on the behavioral manifestations of emotional stress created by a conflict situation. Peptides were shown to have positive emotional effects and antistress actions. Individual physiologically significant effects were seen, due to the molecular struc…

  57. 62.

    Zolotarev IuA, Sokolov OIu, Kost NV, Vas'kovskiĭ BV, et al. · Bioorganicheskaia khimiia · 2004 · PMID 15344652

    A method of analysis of enkephalinase activity in blood plasma based on the application of Leu-enkephalin generally labeled with tritium at all its amino acid residues was developed. The method allows the simultaneous estimation of activity of several peptidases in microquantities of tissues. [G-3H]Leu-enkephalin was prepared by the method of solid phase catalytic isotope exchange (120 Ci/mmol) and subjected to proteolysis by the treatment with blood plasma. The resulting radioactive metabolites…

  58. 63.

    Skrebitskiĭ VG, Kondratenko RV, Povarov IS, Dereviagin VI · Rossiiskii fiziologicheskii zhurnal imeni I.M. Sechenova · 2011 · PMID 22390072

    Effects of two newly synthesized nootropic and anxiolytic dipeptides: Noopept and Selank on inhibitory synaptic transmission in hippocampal CA1 pyramidal cells were investigated using patch-clamp technique in whole-cell configuration. Bath application of Noopept (1 microM) or Selank (2 microM) significantly increased the frequency of spike-dependent spontaneous m1PSCs, whereas spike-independent mlPSCs remained unchanged. It was suggested that both peptides mediated their effect sue to activation…

  59. 64.

    Skvortsova VI, Tvorogova TV, Dubina AI, Burenchev DV, et al. · Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova · 2009 · PMID 20873405

    The aim of this study was to examine Taftsin derivates--macrophage inhibitory factor (MIF, Thr-Lys-Pro) and heptapeptide selank (Thr-Lys-Pro-Arg-Pro-Gly-Pro) in the model of experimental intracerebral hemorrhage in rats. The double autologous blood injection in the basal nucleus was used as a model of intracerebral hemorrhage. Animals ware randomly divided into three groups--the control group (n = 5) was treated with saline, the second group (n = 5) was injected with MIF in dose 150 mkg/ kg/day,…

  60. 65.

    Kozlovskaia MM, Kozlovskiĭ II, Val'dman EA, Seredenin SB · Rossiiskii fiziologicheskii zhurnal imeni I.M. Sechenova · 2002 · PMID 12154572

    Effects of 10 peptides, tuftsin and Selank derivatives upon behavior during emotional stress induced by conflict situation, were studied in Balb/c and C57BL/6 male mice with genetically determined opposite types of emotional stress reaction, in white male mice and in Wistar male rats divided into different groups according to the type of emotional reactivity. Positive effects of some peptides upon the adaptive behavior of animals in stress situation were demonstrated. Individual physiologically…

  61. 66.

    Vanhee C, Francotte A, Janvier S, Deconinck E · Drug testing and analysis · 2020 · PMID 31667971

    At the end of 2017 and 2018 two different unknown suspicious preparations were encountered and were subjected to a plethora of different analyses in order to identify, if present, any bioactive compound. It turned out that these samples contained the assumedly cognitive enhancing research peptides Selank and Semax, which, to our knowledge, have not completed any clinical trials. Moreover, an online search, excluding the dark web, demonstrated that these kinds of nootropic research peptides are f…

  62. 67.

    ANDREEVA LJUDMILA ALEKSANDROVNA, ERSHOV FELIKS IVANOVICH, ZOZULJA ANDREJ ALEKSANDROVICH, MEZENTSEVA MARINA VLADIMIROVNA, MJASOEDOV NIKOLAJ FEDOROVICH, SEREDENIN SERGEJ BORISOVICH, SURGUCHEVA IRINA MIKHAJLOVNA, UCHAKINA OL GA NIKOLAEVNA, UCHAKIN PETR NIKOLAEVICH. · 2008

    FIELD: medicine virology. ^ SUBSTANCE: invention concerns prevention and treatment of virus diseases. For this purpose heptapeptide Selank of formula Thr-Lys-Pro-Arg-Pro-Gly-Pro is applied. ^ EFFECT: invention allows for prevention or relief of virus infection due to evident antiviral activity of agent. ^ 2 cl, 3 tbl, 7 ex, 4 dwg

  63. 68.

    Deigin VI, Poluektova EA, Beniashvili AG, Kozin SA, Poluektov YM. · 2022 · PMID 35456550

    Peptides are low-molecular-weight substances that participate in numerous important physiological functions, such as human growth and development, stress, regulation of the emotional state, sexual behavior, and immune responses. Their mechanisms of action are based on receptor-ligand interactions, which result in highly selective effects. These properties and low toxicity enable them to be considered potent drugs. Peptide preparations became possible at the beginning of the 20th century after a…

Preprints (not yet peer-reviewed)

1
  1. 69.

    Marwaha A, Venkatakrishnan A, Varma G, Shiv S, Hollmer N, Murugadoss K, Gregg CJ, Soundararajan V. · 2026

    Semax and Selank are synthetic regulatory peptides that are not FDA-approved for human use but are marketed direct-to-consumer for cognition, mood and stress resilience. The extent of the documented use of these unapproved peptides in routine clinical care remains poorly characterized and, because neither is dispensed through regulated pathways, is largely absent from structured medication data of Electronic Health Records (EHRs). Using Large Language Model (LLM) curation of de-identified clinic…

Curated sources on file

2
  1. 1.
  2. 2.

Continue reading